DSM-Firmenich Poland sp. z o.o.

Manufacture of food supplements

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2025-02-18
Share capital
8,738,700.00 PLN
Activity description

DSM-Firmenich Poland works in nutrition, health, and beauty, creating nutrients, flavors, and fragrances. Its business areas include perfumery and beauty, taste, texture and health, and health, nutrition and care.

Registered address
ul. Cisowa 19, 64-320 Niepruszewo, Poland
Email
Social media
Electronic delivery address
AE:PL-67549-31455-CBHEW-30

Financials

Filing timeliness

The financial statement for 2025 was filed on time and audited by a statutory auditor.

  • 202514/07/2026
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 1.4%
Division · Manufacture of food products246 / 3,403
Top 7.2%
Sector · Manufacturing985 / 24,548
Top 4.0%
City · Niepruszewo3 / 45
Top 6.7%
Voivodeship · Wielkopolskie366 / 30,850
Top 1.2%
Country · Poland3,165 / 297,069
Top 1.1%

Results vs industry

Revenue
This companyUSD 72.75mMedianUSD 284.01kAverageUSD 6.97m
Net profit
This companyUSD 441.21kMedianUSD 4.93kAverageUSD 683.78k
Operating costs
This companyUSD 70.68mMedianUSD 387.31kAverageUSD 6.05m
Assets
This companyUSD 190.55mMedianUSD 349.52kAverageUSD 6.87m

News

dsm-firmenich brings The Longevity Shift 2.0: The Gut Effect to SupplySide Global 2026

dsm-firmenich brings The Longevity Shift 2.0: The Gut Effect to SupplySide Global 2026

The evolution of dsm-firmenich's immersive longevity experience will explore how better gut health can unlock greater health expectancy, grounded in landmark clinical research and showcased alongside award-winning solutions at booth #6264.

dsm-firmenich launches Biond™ to advance biologics innovation

dsm-firmenich launches Biond™ to advance biologics innovation

dsm-firmenich announces the launch of Biond™, a dedicated portfolio of pharmaceutical-grade vitamins for biopharmaceutical applications.

dsm-firmenich advances patient-centric medical nutrition solutions with focus on taste and enjoyment

dsm-firmenich advances patient-centric medical nutrition solutions with focus on taste and enjoyment

Discover how dsm-firmenich advances patient-centric medical nutrition with taste and sensory solutions designed to improve acceptance, adherence and enjoyment.

dsm-firmenich awards 2026 Nutrition Research Grant to five projects investigating the role of nutrients and bio-actives in supporting healthy longevity in Asia Pacific

dsm-firmenich awards 2026 Nutrition Research Grant to five projects investigating the role of nutrients and bio-actives in supporting healthy longevity in Asia Pacific

dsm-firmenich awards five Nutrition Research Grants to advance healthy longevity research across Asia Pacific, supporting innovative nutrition solutions for healthy aging.

dsm-firmenich's life's®OMEGA innovations named NutraIngredients-USA Award finalists

dsm-firmenich's life's®OMEGA innovations named NutraIngredients-USA Award finalists

Nominations in ingredient and product of the year categories recognize the company’s achievements in advancing omega-3 nutrition from clinical science to consumer shelf.

dsm-firmenich brings its highly acclaimed longevity experience and pioneering science to Vitafoods Europe 2026

dsm-firmenich brings its highly acclaimed longevity experience and pioneering science to Vitafoods Europe 2026

Visitors to booth #3C88 in Barcelona this May can explore how dsm-firmenich is unlocking increased health expectancy with the latest science-backed innovations targeting the cellular hallmarks of aging

Websites

The site is available in: German, French, Spanish, Dutch, Japanese and 2 more. The site targets these markets: Germany, France, Netherlands, Brazil, Japan and 2 more.

Job offers

The company has its own careers page: careers.dsm-firmenich.com/en/careers.html.

Authorized Representatives

Ewa Buczak age 54 – Attorney-in-fact (joint)
Daniele Reale – Management Board Member
Edyta Strojna age 39 – Attorney-in-fact (joint)
Kristina Tahiri – Management Board Member
Małgorzata Matysiak age 40 – Management Board Member

Manner of representation

Two members of the management board jointly, or one member of the management board jointly with a commercial proxy, are authorised to submit declarations of will and sign documents on behalf of the company.

Ownership

OwnerSharesShare valueStake
Dsm B.v.
174,774$2,360,534.85100%

Beneficial owners

Person

Capital group

The company belongs to the DSM-Firmenich AG (Switzerland) group. Its direct owner is DSM B.V. (Netherlands). The group has 21 companies, 19 of them abroad.

NameCountry
ANH Solutions AGSwitzerland
Animal Nutrition & Health Denmark A/SDenmark
Campus S.R.L.Italy
Campus Scandinavia ASNorway
DSM Finance B.V.Netherlands

Bank accounts

Registered as a VAT taxpayer on 2025-06-01.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$1.2M
Buildings and premises
$19.1M

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
Waste generation Active

Competitors

Name
Kerry Polska sp. z o.o.
WD Foods sp. z o.o.
Oleofarm sp. z o.o.
Regis sp. z o.o.
Natubay sp. z o.o.
Master Pharm S.A.
Przedsiębiorstwo Farmaceutyczne Farmapol sp. z o.o.
JAR Aromaty sp. z o.o.
Vimax Flavours & Ingredients sp. z o.o.
Wellmedica sp. z o.o.

Change history

DateEvent
2025-08-25Share capital increase
2025-02-18Entered in the register

FAQ

Last updated: 2026-10-07